Literature DB >> 33480213

Orbitofrontal Hemorrhage and Mild Cognitive Impairment Associated with Othello Syndrome.

Seungyon Koh1,2, Sun Min Lee1,2, So Young Moon3.   

Abstract

Entities:  

Year:  2021        PMID: 33480213      PMCID: PMC7840332          DOI: 10.3988/jcn.2021.17.1.142

Source DB:  PubMed          Journal:  J Clin Neurol        ISSN: 1738-6586            Impact factor:   3.077


× No keyword cloud information.
Dear Editor, Content-specific delusions (CSDs) are delusions that have a specific theme; for example, Othello syndrome (OS)1 is another name for delusion of infidelity. CSDs are often caused by identifiable neurological diseases. We report a patient who had experienced OS over 5 years, which seemed to have developed from multidomain amnestic mild cognitive impairment (MCI) due to Alzheimer's disease (AD) accompanied by an old orbitofrontal hemorrhage. A 62-year-old right-handed female was brought to the dementia clinic presenting with a persistently mistaken belief about her husband. She was illiterate, but could perform her activities of daily living (ADL) as a housewife without problems. Five years prior to this visit she had begun to have morbid suspicions about his infidelity. This delusion increased to the level of physical violence. She did not report any hallucination. Her motor, sensory functions, and reflexes were normal. She scored 19 out of 30 on the Mini Mental State Examination (MMSE). A battery of neuropsychological tests was performed, although this was restricted by her illiteracy. The tests showed marked decrements in memory and naming, with the patient being at the 4.85th percentile for delayed recall in the verbal learning test and at the 14.30th percentile in the Boston Naming Test. Normal findings were obtained in frontal/executive function tests including the contrasting program, go/no-go test, fist-edge-palm test, digit symbol coding, and Controlled Oral Word Association Test. Her global Clinical Dementia Rating (CDR) was 0.5 and CDR-Sum of Boxes was 2. Brain magnetic resonance imaging revealed an encephalomalacic change in the left orbitofrontal cortex, which suggested an old hemorrhagic stroke (Fig. 1A–D). Mild cortical atrophy was evident in the frontal and parietal lobes, whereas the gross findings for hippocampal atrophy were unremarkable (Fig. 1E and F). There were no cerebral microbleeds. 18F-flutemetamol amyloid positron-emission tomography (PET) was performed. Early dynamic brain images acquired 10 min after injecting 18F-flutemetamol showed decreased uptake in the bilateral parietal and left dorsolateral prefrontal/orbitofrontal areas (Fig. 1G).23 Delayed images obtained 90 min after the injection revealed amyloid deposition in the right frontal lobe (Fig. 1H).
Fig. 1

Brain magnetic resonance imaging (MRI) (A–F) and 18F-flutemetamol amyloid positron-emission tomography (PET) (G and H). Brain MRI showed encephalomalacic changes in the left orbitofrontal cortex, suggesting an old hemorrhagic stroke (A–D). Mild cortical atrophy was evident in the frontal and parietal lobes, whereas hippocampal atrophy was grossly unremarkable (E and F). Early dynamic brain 18F-flutemetamol amyloid PET images acquired 10 min after injecting 18F-flutemetamol reveal decreased uptake in the bilateral parietal and left dorsolateral prefrontal regions as well as in the damaged left orbitofrontal region (G). Delayed brain images obtained 90 min after the injection reveal amyloid deposition in the right frontal lobe (H).

The cognitive defects of this patient had gone unnoticed by her family, but she had multidomain amnestic MCI due to AD. She denied any attack of severe headache, but an old orbitofrontal hemorrhage was found incidentally in the absence of cerebral microbleeds, and this did not seem to be associated with amyloid pathology. Therefore, the final diagnosis was made of multidomain amnestic MCI due to AD accompanied by orbitofrontal hemorrhage, both of which seemed to contribute to the development of her OS. The patient was prescribed olanzapine (15 mg), escitalopram (10 mg), and donepezil (5 mg), but her delusion persisted. Over the following year her ability to perform ADL deteriorated. She scored 18 on MMSE, 1 on global CDR, and 5 on CDR–Sum of Boxes. She was judged to have converted to AD dementia. Memantine was added to her medications, and 14 months later she no longer exhibited OS. Delusions begin to develop when unpredicted sensory events are detected but are evaluated in an abnormal manner. Midbrain dopamine neurons respond to unpredicted stimuli, and the detected error signals are conveyed to the striatum, limbic system, and frontal cortex. The right lateral prefrontal cortex is a hub for these mesocorticolimbic projections, and impaired circuitry critically involving this hub leads to delusion. Using voxel-based morphometry analyses, a previous study found greater gray-matter loss predominantly in the dorsolateral frontal lobe in patients with OS.4 Case reports have indicated that structural lesions in the frontal lobes including orbitofrontal lesions56—such as in the present case—and in the right hemisphere are critical to the development of OS.7 Furthermore, a recent lesion network mapping study proposed that the underlying pathobiology of poststroke delusions was not the lesion location itself but rather the disruption of functional connectivity of a network involving the right frontal cortex.8 Our patient exhibited decreased uptake in the dorsolateral prefrontal/orbitofrontal areas during the early phase of 18F-flutemetamol amyloid PET accompanied by an old orbitofrontal hemorrhage, which matched previous reports. This case shows that an orbitofrontal hemorrhage causing disruption of the functional connectivity of a network involving the frontal cortex, combined with neurodegenerative dysfunction in the dorsolateral prefrontal area can synergistically contribute to the development of OS. Like in the present case, delusions can occur during the early to middle stages of degenerative dementia, and disappear when the cognitive deficits become severe.9 However, the lesions in our patient were on the left side, which contrasts with most previous reports. We could not conclude from this single case whether a right-side-dominant hemisphere or left-sided lesions would cause disruption of the functional connectivity of a network involving the right frontal cortex that would lead to the development of OS.
  9 in total

1.  Clinical and imaging features of Othello's syndrome.

Authors:  J Graff-Radford; J L Whitwell; Y E Geda; K A Josephs
Journal:  Eur J Neurol       Date:  2011-04-25       Impact factor: 6.089

2.  Finding the imposter: brain connectivity of lesions causing delusional misidentifications.

Authors:  R Ryan Darby; Simon Laganiere; Alvaro Pascual-Leone; Sashank Prasad; Michael D Fox
Journal:  Brain       Date:  2017-01-12       Impact factor: 13.501

3.  Othello syndrome secondary to right orbitofrontal lobe excision.

Authors:  Jin Narumoto; Kaeko Nakamura; Yurinosuke Kitabayashi; Kenji Fukui
Journal:  J Neuropsychiatry Clin Neurosci       Date:  2006       Impact factor: 2.198

4.  Othello syndrome in a patient with right orbitofrontal lobe cavernous sinus hemorrhage.

Authors:  Chiu-Ping Hsiao; Nian-Sheng Tzeng; Chun-Jung Juan; Shin-I Ma
Journal:  J Neuropsychiatry Clin Neurosci       Date:  2013       Impact factor: 2.198

5.  Prevalence of delusional jealousy in different psychiatric disorders. An analysis of 93 cases.

Authors:  M Soyka; G Naber; A Völcker
Journal:  Br J Psychiatry       Date:  1991-04       Impact factor: 9.319

6.  Erotomania and senile dementia of Alzheimer type.

Authors:  W C Drevets; E H Rubin
Journal:  Br J Psychiatry       Date:  1987-09       Impact factor: 9.319

Review 7.  The frontal lobes and content-specific delusions.

Authors:  P F Malloy; E D Richardson
Journal:  J Neuropsychiatry Clin Neurosci       Date:  1994       Impact factor: 2.198

8.  Evaluation of early-phase [18F]-florbetaben PET acquisition in clinical routine cases.

Authors:  Sonja Daerr; Matthias Brendel; Christian Zach; Erik Mille; Dorothee Schilling; Mathias Johannes Zacherl; Katharina Bürger; Adrian Danek; Oliver Pogarell; Andreas Schildan; Marianne Patt; Henryk Barthel; Osama Sabri; Peter Bartenstein; Axel Rominger
Journal:  Neuroimage Clin       Date:  2016-10-08       Impact factor: 4.881

9.  Optimized dual-time-window protocols for quantitative [18F]flutemetamol and [18F]florbetaben PET studies.

Authors:  Fiona Heeman; Maqsood Yaqub; Isadora Lopes Alves; Kerstin Heurling; Johannes Berkhof; Juan Domingo Gispert; Santiago Bullich; Christopher Foley; Adriaan A Lammertsma
Journal:  EJNMMI Res       Date:  2019-03-27       Impact factor: 3.138

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.